First Dose of BNT162b2 mRNA Vaccine in a Healthcare Worker Cohort Is Associated With Reduced Symptomatic and Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

Over the first 2 months of 2021, vaccination coverage of staff at Hull Teaching Hospitals with BNT162b2 increased from 8.3% to 82.5% and was associated with a significant reduction in symptomatic and asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cases. The proportion of p...

Descripción completa

Detalles Bibliográficos
Autores principales: Lillie, Patrick J, O’Brien, Paul, Lawtie, Michelle, Jessop, Steve, Easom, Nicholas J W, Patmore, Russell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135606/
https://www.ncbi.nlm.nih.gov/pubmed/33893480
http://dx.doi.org/10.1093/cid/ciab351
_version_ 1783695354875609088
author Lillie, Patrick J
O’Brien, Paul
Lawtie, Michelle
Jessop, Steve
Easom, Nicholas J W
Patmore, Russell
author_facet Lillie, Patrick J
O’Brien, Paul
Lawtie, Michelle
Jessop, Steve
Easom, Nicholas J W
Patmore, Russell
author_sort Lillie, Patrick J
collection PubMed
description Over the first 2 months of 2021, vaccination coverage of staff at Hull Teaching Hospitals with BNT162b2 increased from 8.3% to 82.5% and was associated with a significant reduction in symptomatic and asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cases. The proportion of positive lateral flow tests from asymptomatic screening was maintained over this period.
format Online
Article
Text
id pubmed-8135606
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-81356062021-05-21 First Dose of BNT162b2 mRNA Vaccine in a Healthcare Worker Cohort Is Associated With Reduced Symptomatic and Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Lillie, Patrick J O’Brien, Paul Lawtie, Michelle Jessop, Steve Easom, Nicholas J W Patmore, Russell Clin Infect Dis Brief Reports Over the first 2 months of 2021, vaccination coverage of staff at Hull Teaching Hospitals with BNT162b2 increased from 8.3% to 82.5% and was associated with a significant reduction in symptomatic and asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cases. The proportion of positive lateral flow tests from asymptomatic screening was maintained over this period. Oxford University Press 2021-04-23 /pmc/articles/PMC8135606/ /pubmed/33893480 http://dx.doi.org/10.1093/cid/ciab351 Text en © The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Reports
Lillie, Patrick J
O’Brien, Paul
Lawtie, Michelle
Jessop, Steve
Easom, Nicholas J W
Patmore, Russell
First Dose of BNT162b2 mRNA Vaccine in a Healthcare Worker Cohort Is Associated With Reduced Symptomatic and Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
title First Dose of BNT162b2 mRNA Vaccine in a Healthcare Worker Cohort Is Associated With Reduced Symptomatic and Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
title_full First Dose of BNT162b2 mRNA Vaccine in a Healthcare Worker Cohort Is Associated With Reduced Symptomatic and Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
title_fullStr First Dose of BNT162b2 mRNA Vaccine in a Healthcare Worker Cohort Is Associated With Reduced Symptomatic and Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
title_full_unstemmed First Dose of BNT162b2 mRNA Vaccine in a Healthcare Worker Cohort Is Associated With Reduced Symptomatic and Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
title_short First Dose of BNT162b2 mRNA Vaccine in a Healthcare Worker Cohort Is Associated With Reduced Symptomatic and Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
title_sort first dose of bnt162b2 mrna vaccine in a healthcare worker cohort is associated with reduced symptomatic and asymptomatic severe acute respiratory syndrome coronavirus 2 (sars-cov-2) infection
topic Brief Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135606/
https://www.ncbi.nlm.nih.gov/pubmed/33893480
http://dx.doi.org/10.1093/cid/ciab351
work_keys_str_mv AT lilliepatrickj firstdoseofbnt162b2mrnavaccineinahealthcareworkercohortisassociatedwithreducedsymptomaticandasymptomaticsevereacuterespiratorysyndromecoronavirus2sarscov2infection
AT obrienpaul firstdoseofbnt162b2mrnavaccineinahealthcareworkercohortisassociatedwithreducedsymptomaticandasymptomaticsevereacuterespiratorysyndromecoronavirus2sarscov2infection
AT lawtiemichelle firstdoseofbnt162b2mrnavaccineinahealthcareworkercohortisassociatedwithreducedsymptomaticandasymptomaticsevereacuterespiratorysyndromecoronavirus2sarscov2infection
AT jessopsteve firstdoseofbnt162b2mrnavaccineinahealthcareworkercohortisassociatedwithreducedsymptomaticandasymptomaticsevereacuterespiratorysyndromecoronavirus2sarscov2infection
AT easomnicholasjw firstdoseofbnt162b2mrnavaccineinahealthcareworkercohortisassociatedwithreducedsymptomaticandasymptomaticsevereacuterespiratorysyndromecoronavirus2sarscov2infection
AT patmorerussell firstdoseofbnt162b2mrnavaccineinahealthcareworkercohortisassociatedwithreducedsymptomaticandasymptomaticsevereacuterespiratorysyndromecoronavirus2sarscov2infection

Ejemplares similares